Is CXW a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for CoreCivic (CXW) rests on Reactivating idle beds: The clearest earnings lever is turning facilities that were sitting empty back into contracted, occupied capacity. The bear case rests on the concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. Analysts covering it publish targets from $40.00 to $45.00 against a $30.97 share price on November 16, 2026, so even the professionals disagree by 12% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
CXW key stats
At $30.97 on November 16, 2026, CoreCivic (CXW) has a market cap of $2.7B and a P/E of 2.1 on trailing earnings (13.5 on forward earnings).
- Market cap
- $2.7B
- P/E (trailing)
- 2.1
- P/E (forward)
- 13.5
- EPS (trailing 12 months)
- $15.11
- Price to book
- 1.2
- Beta
- 0.66
Market cap, P/E and yield are measured at the $30.97 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with CoreCivic (CXW)?
The last two weeks for CoreCivic, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- CXW closed at $30.97 on November 16, 2026, up 3.8% over the past five trading days (from $29.83).
- On November 5, 2026, CoreCivic filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
- On November 4, 2026, CoreCivic filed an 8-K with the SEC reporting quarterly results and other events (Item 2.02, Item 8.01). Read the 8-K on sec.gov
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
CoreCivic, based in Nashville, owns, leases and operates correctional, detention and residential reentry facilities under contract with government agencies. It is paid mainly a per diem rate for each resident housed each day, which makes occupancy and contracted bed counts the two numbers that drive results. Its customers are US Immigration and Customs Enforcement, the US Marshals Service, state departments of correction, and county and local governments. Residential occupancy was 78.4% in the second quarter of 2026, up from 76.8% a year earlier. The company also leases real estate to government tenants and, since April 2026, owns a correctional pharmacy business bought for about $199.8 million that serves more than 600 facilities across 32 states. The investment picture in 2026 has two moving parts. The first is growth: federal detention spending has let CoreCivic reactivate idle facilities including Dilley, California City, Diamondback and, from August 2026, the 1,600-bed Prairie Correctional Facility in Minnesota that had been empty since 2010, and five recently activated sites alone produced $80.1 million of revenue and $21.1 million of operating income in the second quarter. The second is a balance-sheet reset: CoreCivic sold four facilities to the Department of Homeland Security for roughly $2.2 billion gross, used $608.5 million of it to repay debt, and expanded its buyback authorization to $1.2 billion. Selling the real estate while continuing to manage the sites converts owned-and-operated economics into lower-margin management fees, which is why full-year adjusted EBITDA guidance came down even as revenue grew. CoreCivic gave up its REIT status effective January 2021, is taxed as an ordinary C corporation, and has paid no dividend since 2020. Leadership has turned over quickly: Patrick Swindle, who succeeded longtime CEO Damon Hininger on January 1, 2026, stepped down in late September 2026 to undergo treatment for Stage 4 pancreatic cancer, and Lucibeth Mayberry, with CoreCivic since 2003 and chief strategy officer since May 2025, became president and CEO. At about $30 per share in mid-October 2026 the company is valued near $3.0 billion.
The bull case: what would have to be true for $45.00
The most optimistic published target on CXW is $45.00, +45.3% from the $30.97 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Reactivating idle beds
The clearest earnings lever is turning facilities that were sitting empty back into contracted, occupied capacity. Dilley, West Tennessee, California City, Diamondback and the Midwest Regional Reception Center were all activated on new awards and together contributed $80.1 million of revenue in the second quarter of 2026. The 1,600-bed Prairie facility, idle since 2010, started a five-year ICE contract on August 11, 2026, and is expected to produce roughly $75 million of annual revenue once fully staffed and filled.
2. Federal detention demand
Federal customers, chiefly ICE and the US Marshals Service, generated about 53% of total revenue in the second quarter of 2026, with federal revenue up $78.2 million, or 27.2%, year over year. Total revenue reached $684.9 million in the quarter, a 27.3% increase. This is a demand story set by appropriations and enforcement policy rather than by pricing power, so the durability of the current spending level is the variable that matters most. DHS is also moving to own more capacity across the sector: in October 2026 it bought three detention facilities from GEO Group for about $950 million, a sign the government-ownership model is spreading beyond CoreCivic.
3. Cash from the DHS sales and what it funds
CoreCivic sold Otay Mesa, California City, Prairie and the Midwest Regional Reception Center to DHS for about $2.2 billion gross, roughly $307,000 per bed, with expected net proceeds near $1.6 billion and an accounting gain around $1.8 billion booked in the third quarter. It repaid $608.5 million of debt, cutting total debt to roughly $739 million, and the board added $500 million to the repurchase authorization, leaving about $756 million available. How the remaining cash is deployed is a live question for shareholders. A new CEO now makes that call: Lucibeth Mayberry, who ran real estate from 2016 to 2022, took over in late September 2026, which puts someone with a property background in charge of the capital-allocation decision.
4. Services beyond beds
The April 2026 purchase of a correctional pharmacy business for about $199.8 million extends CoreCivic into a service sold to more than 600 facilities in 32 states, including many it does not operate. It is small next to the detention business but is not tied to CoreCivic's own occupancy. Whether management builds further in adjacent correctional services will shape how concentrated the revenue base stays.
The bear case: what would have to be true for $40.00
The most pessimistic published target is $40.00, +29.2% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks CoreCivic is worth if the risks below bite instead of the drivers above.
The concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. A 2021 executive order directing the Justice Department not to renew private prison contracts removed CoreCivic's Bureau of Prisons business, a worked example of how fast policy can subtract revenue, and several states including California, Illinois, New Jersey and Washington restrict private detention outright. ESG exclusion is a structural overhang rather than a headline problem: numerous funds screen the sector out and several large banks stopped lending to private prison operators after 2019, which narrows both the shareholder base and financing options, and was part of the backdrop to the REIT exit. Selling facilities to DHS raises cash but leaves CoreCivic managing beds it no longer owns, which lowers margins and shortens the tie between the company and the assets. Staffing costs, occupancy swings, litigation and reputational scrutiny round out the operating risks. Management continuity is now a risk in its own right: Mayberry is the third CEO in about ten months after Patrick Swindle's resignation for health reasons in September 2026, and the shares fell about 15% in the month to mid-October.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CXW already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on CXW
5 analysts cover CXW, with an average target of $41.80 (+35.0% against $30.97) and a split of 4 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CXW forecast and price target page.
How is CXW valued?
Market cap, P/E and dividend yield at today's price are in the CXW key stats above. The business figures below come from CoreCivic's reported results as of October 2026 and change when it next reports.
- Revenue (TTM): ~$2.48B
- Q2 2026 revenue: ~$684.9M (+27.3% YoY)
- Q2 2026 adjusted EPS: ~$0.38 vs ~$0.34 consensus
- FY2026 adjusted diluted EPS guidance: ~$1.62 to $1.70
- FY2026 adjusted EBITDA guidance: ~$440.5M to $445.5M (cut from ~$453.8M to $461.8M)
- Total debt after repayments: ~$739M (after repaying ~$608.5M)
As of October 2026: The headline GAAP numbers for 2026 are distorted by the DHS transactions: guided diluted EPS of about $15.00 to $15.20 reflects a roughly $1.8 billion one-time gain, while adjusted diluted EPS of about $1.62 to $1.70 is the figure that describes the ongoing business. At a share price near $30.08 on October 16, 2026, that puts the stock around 18 times the midpoint of adjusted earnings and about 12 times analysts' 2027 EPS estimate of about $2.42. Adjusted EBITDA guidance was reduced even as revenue guidance rose, because facilities sold to DHS shift from owned-and-operated to managed-only. Consensus for the November 4 third-quarter report is EPS near $0.43 on revenue near $701 million.
How do you decide if CXW is a buy?
Whether CXW is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CXW indirectly through an index or sector ETF before adding more.
What would change your mind on CXW
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Reactivating idle beds stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: the concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the CXW stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CXW against your real portfolio and see your actual exposure before deciding.
Your questions about CoreCivic
Ask Walnut's AI anything about CXW and see how it fits what you own.
FAQ
Is CXW a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Reactivating idle beds, with revenue (ttm) at ~$2.48B. The bear case rests on the concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. Analysts covering it are spread from $40.00 to $45.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell CXW?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $40.00, +29.2% from the $30.97 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for CXW?
+
Reactivating idle beds. The clearest earnings lever is turning facilities that were sitting empty back into contracted, occupied capacity. The most optimistic analyst target on CXW is $45.00, +45.3% from the $30.97 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for CXW?
+
The concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. A 2021 executive order directing the Justice Department not to renew private prison contracts removed CoreCivic's Bureau of Prisons business, a worked example of how fast policy can subtract revenue, and several states including California, Illinois, New Jersey and Washington restrict private detention outright. ESG exclusion is a structural overhang rather than a headline problem: numerous funds screen the sector out and several large banks stopped lending to private prison operators after 2019, which narrows both the shareholder base and financing options, and was part of the backdrop to the REIT exit. Selling facilities to DHS raises cash but leaves CoreCivic managing beds it no longer owns, which lowers margins and shortens the tie between the company and the assets. Staffing costs, occupancy swings, litigation and reputational scrutiny round out the operating risks. Management continuity is now a risk in its own right: Mayberry is the third CEO in about ten months after Patrick Swindle's resignation for health reasons in September 2026, and the shares fell about 15% in the month to mid-October. The most pessimistic published target is $40.00, +29.2% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does CoreCivic do?
+
Owner and operator of correctional and detention facilities under government contract, with ICE and the US Marshals supplying most of its revenue.
What would have to change for CXW to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Reactivating idle beds) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does CoreCivic do?
+
CoreCivic owns, leases and operates correctional, detention and residential reentry facilities under contract with government agencies. Its largest customers are US Immigration and Customs Enforcement and the US Marshals Service, followed by state departments of correction and local governments. It is generally paid a per diem rate for each resident housed each day, so occupancy and contracted bed counts drive results. In April 2026 it also acquired a correctional pharmacy business.
Is CoreCivic still a REIT?
+
No. CoreCivic operated as a real estate investment trust until it revoked that election effective January 1, 2021, and it has been taxed as an ordinary C corporation since. The change let it retain cash flow to reduce debt rather than distribute it, at the cost of paying corporate income tax. It still reports funds from operations, a metric carried over from the REIT years, which can confuse comparisons.
Does CXW pay a dividend?
+
CoreCivic suspended its quarterly dividend in 2020 while it reviewed its corporate structure and capital allocation, and it has not reinstated one. Capital has gone to debt reduction and share repurchases instead. The board expanded the buyback authorization by $500 million in 2026 to $1.2 billion in total, with roughly $756 million still available after the facility sales to the Department of Homeland Security.
Walnut is informational, not investment advice, and gives no verdict on CXW. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.